Wed, February 24, 2021
Tue, February 23, 2021
Mon, February 22, 2021

Joseph Pantginis Maintained (BLRX) at Strong Buy with Decreased Target to $19 on, Feb 23rd, 2021

Joseph Pantginis of HC Wainwright & Co., Maintained "BioLineRx Ltd." (BLRX) at Strong Buy with Decreased Target from $22 to $19 on, Feb 23rd, 2021.

Joseph, nor any peers, have made any analyst calls on BLRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30